A Phase 1 Study of ASN004 in Patients With Advanced Solid Tumors
Conditions: Breast Cancer; Breast Neoplasms; Breast Adenocarcinoma; Breast Cancer Recurrent; Breast Cancer Metastatic; Breast Cancer Invasive; Non-small Cell Lung Cancer; Non-small Cell Carcinoma; Non-small Cell Lung Cancer Recurrent; Non-Small Cell Squamous L ung Carcinoma; Non-Small Cell Adenocarcinoma; Non-small Cell Lung Cancer Metastatic; Colorectal Cancer; Colorectal Neoplasms; Colorectal Carcinoma; Colorectal Adenocarcinoma; Colorectal Cancer Metastatic; Colorectal (Colon or Rectal) Cancer; Colon Cancer; Colon Neoplasm; Ovarian Cancer; Ovarian Neoplasm; Ovarian Cancer Recurrent; Carcinoma, Ovarian Epithelial; Carcinoma Ovary; Carcinoma Colon; Carcinoma Breast; Carcinoma, Non-Small-Cell Lung Intervention: Drug: ASN004 Sponsor: Asana BioSciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Colon Cancer | Colorectal Cancer | Epithelial Cancer | Ovaries | Research | Study